The February 2026 meta-analysis confirms that 308 nm Excimer Laser therapy, reliably produces significant improvement in plaque psoriasis. STRATA Skin Sciences remains committed to advancing clinical ...
STRATA Skin Sciences announces a study validating its Excimer Laser technology's superiority in treating dermatological conditions compared to traditional UVB sources. STRATA Skin Sciences, Inc.
The MarketWatch News Department was not involved in the creation of this content. HORSHAM, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN) ...
HORSHAM, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
HORSHAM, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and ...
HORSHAM, Pa., May 19, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to advancing dermatologic care through ...
“This latest clinical study further validates the superiority of Strata Skin Sciences’ advanced technologies embedded in the XTRAC ® Excimer Laser over other (less accurate, non-collimated, lower ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results